ArticleFrontiers in cardiovascular medicine2025
Diastolic function and cardiovascular events in patients with preserved left ventricular ejection fraction. Improving risk stratification with left atrial strain.
Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Echocardiographic Markers and Outcomes in End-Stage Liver Disease.Journal of clinical medicine · 2026Article
- Echocardiographic Assessment of Left Ventricular Diastolic Function in Adults Between Old and New: Progress and Challenges.Diagnostics (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: A limited number of studies have examined the prognostic significance of diastolic function in patients with preserved left ventricular ejection fraction (LVEF) in a general population referred for transthoracic echocardiography. Our aim was to assess the association between diastolic function and a combined event in which the left atrium plays a pivotal role, including heart failure (HF), atrial fibrillation (AF) and ischemic stroke. The study sought to determine the incremental value of left atrial reservoir strain (LARS) in risk stratification. Methods: We performed a retrospective analysis of 364 patients with preserved LVEF and sinus rhythm referred for transthoracic echocardiography and categorized them into four groups based on their diastolic function status according to the 2016 ASE/EACVI guidelines: normal diastolic function (NDF), indeterminate diastolic function and diastolic dysfunction with indeterminate filling pressure (IDT), grade 1 diastolic dysfunction (DD1), and diastolic dysfunction with elevated filling pressure (DD-EFP). The primary endpoint was a composite of HF, AF or ischemic stroke. LARS was measured by 2D speckle tracking. Clinical parameters, comorbidities and specific cardiac diseases were also assessed. Secondary endpoint was all-cause mortality. Results: The mean follow-up period was 2.4 years. IDT and DD-EFP diastolic function status were independently associated with the combined event. The incorporation of LARS enhanced risk stratification, particularly in IDT patients, with a cutoff of ≤24% identifying a high-risk population. Patients classified as high risk, defined as those with DD-EFP and IDT with LARS ≤ 24%, exhibited a notable event rate of 34% and 46%, respectively. Diastolic function and LARS were not independently associated with all-cause mortality. Conclusions: In patients with preserved LVEF and sinus rhythm, diastolic function is strongly and independently associated with the combined event of HF, AF, or ischemic stroke. LARS provides a valuable tool for improving risk stratification in this population. Patients at high risk (DD-EFP and IDT with LARS ≤ 24%) demonstrated a significant event rate, underscoring the necessity for preventive measures. Diastolic function and LARS were not independently associated with all-cause mortality. Further studies are required to confirm these findings and validate the proposed approach.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.